当前抗-HCV检测的信号与 Cutoff 比值及补充检测新算法建议
对346份阳性样本用Elecsys和Vitros复检,低S/Co样本(0.9-10.0)符合率较低;逻辑回归显示预测95%阳性概率的S/Co为3.13,50%概率为8.85。作者提出用第二种试剂复检的补充检测算法。
要点
- 抗-HCV筛查阳性需补充检测以区分真阳性与生物学假阳性。
- 低S/Co样本不同试剂间符合率低,Architect-Elecsys仅35.2%。
- S/Co预测95%阳性概率的阈值为3.13,50%概率为8.85。
核心结论
- 抗-HCV筛查结果需要补充检测以区分真阳性和生物学假阳性。
- 本研究提出用第二种试剂复检的补充检测算法,可供临床实验室使用。
研究设计与样本
- 对346份抗-HCV阳性样本用Elecsys(Roche)和Vitros(Ortho)复检。
- 对147份和11份抗-HCV阳性样本分别进行HCV RNA PCR和重组免疫印迹试验(RIBA)。
主要发现
- 低S/Co样本(0.9-10.0)符合率:Architect-Elecsys 35.2%,Architect-Vitros 43.8%,Elecsys-Vitros 81.9%。
- S/Co比值相关系数:Architect-Elecsys 0.20,Architect-Vitros 0.42,Elecsys-Vitros 0.46。
- 逻辑回归中预测95%阳性概率的S/Co值为3.13,预测50%概率的S/Co值为8.85。
- RIBA中S/Co 1.70-3.34时5种抗原中1种反应,S/Co 13.54-17.72时5种抗原中3至5种阳性。
关键数值与推荐
- 低S/Co样本定义为0.9-10.0。
- 预测95%阳性概率的S/Co阈值为3.13,预测50%概率的S/Co阈值为8.85。
临床怎么用
- 抗-HCV筛查阳性时,建议用第二种抗-HCV试剂复检作为补充检测策略。
- 低S/Co样本需警惕假阳性,应结合复检及核酸检测结果综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The detection of hepatitis C virus antibody (anti-HCV) is known to have high false-positive rates. Using signal-to-cutoff (S/Co) ratios in reflex supplemental testing, however, could reduce false-positive rates. Here, we analyzed the 2-year data of an anti-HCV assay to understand the significance of the S/Co ratio and make a new algorithm by confirming with a second anti-HCV assay. METHODS: We reviewed 32,573 samples of the Architect assay (Abbott Diagnostics) from a tertiary hospital. Retests with the Elecsys (Roche Diagnostics) and Vitros (Ortho Clinical Diagnostics) assays were performed in 346 anti-HCV-positive samples. HCV RNA PCR and recombinant immunoblot assay (RIBA) were performed in 147 and 11 anti-HCV-positive samples, respectively. RESULTS: Among 32,573 samples, 446 (1.37%) yielded positive results and 32,127 (98.6%) yielded negative results. Concordance rates in low S/Co samples (0.9-10.0) were 35.2%, 43.8%, and 81.9% for the Architect-Elecsys, Architect-Vitros, and Elecsys-Vitros comparisons, respectively. Correlation coefficients of S/Co ratios were as follows: Architect-Elecsys, 0.20; Architect-Vitros, 0.42; and Elecsys-Vitros, 0.46. In logistic regression, the S/Co value for predicting positivity with 95% probability was 3.13, while that for predicting 50% probability was 8.85. S/Co ratios of 1.70-3.34 showed one reactive antigen out of five antigens, and S/Co ratios of 13.54-17.72 showed three to five positive reactions out of five antigens used in the RIBA. CONCLUSIONS: Supplementary testing of anti-HCV screening results is necessary to distinguish between true positivity and biological false positivity for anti-HCV. In this study, we presented an algorithm of supplementary testing by a retest with a second reagent, which could be useful in clinical laboratories.
引用
- Ha J, Park Y, Kim HS, et al. Signal-to-cutoff ratios of current anti-HCV assays and a suggestion of new algorithm of supplementary testing. Clin Chim Acta. 2019. PMID: 31400313. doi:10.1016/j.cca.2019.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。